Lewicki John A.
Insider CIK 1553352 · OMED President and CEO, Director · MREO Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MREO Mereo BioPharma Group plc | A Award deriv | 2026-02-01 | 2026-02-02 | 145,000 | — | $0 | 145,000 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2026-02-01 | 2026-02-02 | 139,913 | — | $0 | 139,913 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2026-02-01 | 2026-02-02 | 46,637 | — | $0 | 46,637 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2025-01-25 | 2025-01-28 | 116,000 | — | $0 | 116,000 | SEC↗ |
| MREO Mereo BioPharma Group plc | S Sale | 2024-09-13 | 2024-09-16 | 10,937 | $4.22 | $46.2K | 78,630 | SEC↗ |
| MREO Mereo BioPharma Group plc | S Sale | 2024-09-12 | 2024-09-16 | 5,212 | $4.47 | $23.3K | 89,567 | SEC↗ |
| MREO Mereo BioPharma Group plc | M Exercise deriv | 2024-09-11 | 2024-09-13 | 46,000 | — | $0 | 0 | SEC↗ |
| MREO Mereo BioPharma Group plc | M Exercise | 2024-09-11 | 2024-09-13 | 46,000 | — | $0 | 94,779 | SEC↗ |
| MREO Mereo BioPharma Group plc | S Sale | 2024-06-26 | 2024-06-27 | 16,808 | $3.39 | $57.0K | 48,779 | SEC↗ |
| MREO Mereo BioPharma Group plc | S Sale | 2024-06-25 | 2024-06-27 | 7,416 | $3.69 | $27.4K | 65,587 | SEC↗ |
| MREO Mereo BioPharma Group plc | M Exercise deriv | 2024-06-21 | 2024-06-25 | 69,000 | — | $0 | 46,000 | SEC↗ |
| MREO Mereo BioPharma Group plc | M Exercise | 2024-06-21 | 2024-06-25 | 69,000 | — | $0 | 73,003 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2024-01-25 | 2024-01-26 | 137,000 | — | $0 | 137,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | U Tender | 2019-04-23 | 2019-04-23 | 142,534 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2018-10-10 | 2018-10-11 | 1,156 | $2.01 | $2.3K | 55,966 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2018-10-09 | 2018-10-10 | 2,296 | $2.13 | $4.9K | 57,122 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2018-04-24 | 2018-04-26 | 4,557 | $2.68 | $12.2K | 55,418 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2018-03-16 | 2018-03-19 | 125,000 | — | $0 | 125,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2018-02-21 | 2018-02-23 | 125,000 | — | $0 | 125,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2018-01-04 | 2018-01-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-10-10 | 2017-10-12 | 46 | $4.26 | $196 | 71,614 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-10-10 | 2017-10-12 | 1,202 | $4.24 | $5.1K | 70,412 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2017-10-07 | 2017-10-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award | 2017-10-07 | 2017-10-10 | 25,000 | — | $0 | 71,660 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2017-04-23 | 2017-04-25 | 67,500 | — | $0 | 67,500 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award | 2017-04-23 | 2017-04-25 | 22,500 | — | $0 | 45,437 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-04-04 | 2017-04-05 | 43 | $8.87 | $381 | 28,648 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-04-04 | 2017-04-05 | 5,711 | $9.06 | $51.7K | 22,937 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2017-01-03 | 2017-01-05 | 65,000 | — | $0 | 65,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2017-01-03 | 2017-01-05 | 9,175 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2017-01-03 | 2017-01-05 | 9,175 | $7.63 | $70.0K | 31,636 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2017-01-03 | 2017-01-05 | 9,175 | $1.43 | $13.1K | 40,811 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award | 2016-10-09 | 2016-10-11 | 12,500 | — | $0 | 31,636 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2016-01-07 | 2016-01-08 | 1 | $21.33 | $21 | 17,838 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2016-01-06 | 2016-01-08 | 69 | $21.56 | $1.5K | 17,839 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2016-01-06 | 2016-01-08 | 2,092 | $22.30 | $46.7K | 17,908 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2015-12-27 | 2015-12-29 | 70,000 | — | $0 | 70,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-06-16 | 2015-06-17 | 2,898 | — | $0 | 134,423 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-06-16 | 2015-06-17 | 5,602 | — | $0 | 9,175 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-06-16 | 2015-06-17 | 5,602 | $1.43 | $8.0K | 25,602 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-06-16 | 2015-06-17 | 2,898 | $3.42 | $9.9K | 28,500 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-06-16 | 2015-06-17 | 8,500 | $25.22 | $214.4K | 20,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-06-15 | 2015-06-17 | 8,500 | — | $0 | 14,777 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-06-15 | 2015-06-17 | 8,500 | $24.92 | $211.8K | 20,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-06-15 | 2015-06-17 | 8,500 | $1.43 | $12.2K | 28,500 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-04-02 | 2015-04-03 | 8,500 | — | $0 | 23,277 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-04-02 | 2015-04-03 | 8,500 | $1.43 | $12.2K | 29,785 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-04-02 | 2015-04-03 | 1,560 | $25.70 | $40.1K | 21,285 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-04-02 | 2015-04-03 | 6,940 | $25.29 | $175.5K | 22,845 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-04-01 | 2015-04-03 | 8,500 | — | $0 | 31,777 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-04-01 | 2015-04-03 | 8,500 | $1.43 | $12.2K | 29,785 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-04-01 | 2015-04-03 | 8,500 | $25.19 | $214.1K | 21,285 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-02-02 | 2015-02-04 | 4,000 | — | $0 | 40,277 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-02-02 | 2015-02-04 | 4,000 | — | $0 | 40,277 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-02-02 | 2015-02-04 | 4,000 | $1.43 | $5.7K | 24,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-02-02 | 2015-02-04 | 4,000 | $22.49 | $90.0K | 20,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2015-01-02 | 2015-01-05 | 4,000 | — | $0 | 44,277 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-01-02 | 2015-01-05 | 400 | $22.79 | $9.1K | 20,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2015-01-02 | 2015-01-05 | 4,000 | $1.43 | $5.7K | 24,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2015-01-02 | 2015-01-05 | 3,600 | $22.03 | $79.3K | 20,400 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2014-12-18 | 2014-12-22 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2014-12-01 | 2014-12-03 | 4,000 | — | $0 | 48,277 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-12-01 | 2014-12-03 | 4,000 | $21.19 | $84.8K | 20,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2014-12-01 | 2014-12-03 | 4,000 | $1.43 | $5.7K | 24,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2014-11-03 | 2014-11-05 | 4,000 | — | $0 | 52,277 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2014-11-03 | 2014-11-05 | 4,000 | $1.43 | $5.7K | 24,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-11-03 | 2014-11-05 | 4,000 | $20.45 | $81.8K | 20,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2014-10-02 | 2014-10-03 | 5,809 | — | $0 | 56,277 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-10-02 | 2014-10-03 | 5,809 | $20.00 | $116.2K | 20,602 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2014-10-02 | 2014-10-03 | 5,809 | $1.43 | $8.3K | 26,411 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | G Gift | 2014-09-18 | 2014-11-05 | 602 | — | $0 | 83,530 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | G Gift | 2014-09-08 | 2014-11-05 | 602 | — | $0 | 20,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2014-09-02 | 2014-09-03 | 2,191 | — | $0 | 62,086 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2014-09-02 | 2014-09-03 | 2,191 | $1.43 | $3.1K | 22,793 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-09-02 | 2014-09-03 | 2,191 | $20.01 | $43.8K | 20,602 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2014-08-01 | 2014-08-04 | 4,000 | — | $0 | 64,277 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-08-01 | 2014-08-04 | 4,000 | $20.98 | $83.9K | 20,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2014-08-01 | 2014-08-04 | 4,000 | $1.43 | $5.7K | 24,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2014-07-01 | 2014-07-03 | 4,000 | — | $0 | 68,277 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2014-07-01 | 2014-07-03 | 4,000 | $1.43 | $5.7K | 24,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-07-01 | 2014-07-03 | 704 | $24.36 | $17.1K | 20,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-07-01 | 2014-07-03 | 3,296 | $23.75 | $78.3K | 20,704 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-06-16 | 2014-07-03 | 2,638 | $24.79 | $65.4K | 20,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-06-16 | 2014-07-03 | 1,362 | $24.19 | $32.9K | 22,638 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise deriv | 2014-06-16 | 2014-06-17 | 4,000 | — | $0 | 72,277 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | M Exercise | 2014-06-16 | 2014-06-17 | 4,000 | $1.43 | $5.7K | 24,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-06-16 | 2014-06-17 | 4,000 | $24.59 | $98.4K | 20,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award | 2014-03-25 | 2014-03-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | G Gift | 2014-03-20 | 2014-03-27 | 1,792 | — | $0 | 82,928 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | G Gift | 2014-03-20 | 2014-03-27 | 1,792 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | G Gift | 2014-03-06 | 2014-03-12 | 81,136 | — | $0 | 1,792 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | G Gift | 2014-03-06 | 2014-03-12 | 81,136 | — | $0 | 81,136 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 3,132 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 5,159 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 5,159 | — | $0 | 81,136 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 3,132 | — | $0 | 75,977 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2013-07-17 | 2013-07-19 | 14,000 | — | $0 | 14,000 | SEC↗ |